Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The Role of Community Pharmacies in Respiratory Disease Control.

Castillo D, Burgos F, Gascón MP.

Arch Bronconeumol. 2015 Sep;51(9):429-30. doi: 10.1016/j.arbres.2015.06.003. Epub 2015 Jul 2. English, Spanish. No abstract available.

2.

The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.

Kruithof EK, Mestries JC, Gascon MP, Ythier A.

Thromb Haemost. 1997 May;77(5):905-10.

PMID:
9184401
3.

The effect of factor Xa/phospholipid infusion on the acute phase response in baboons.

Kruithof EK, Agay D, Mestries JC, Gascon MP, Ythier A.

Thromb Haemost. 1997 Feb;77(2):308-11.

PMID:
9157587
4.

Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.

Porat R, Paddock HN, Schwaitzberg SD, Connolly RJ, Wilkens T, Dasch JR, Gascon MP, Hutchison JS, Ythier A, Wallach D, et al.

Crit Care Med. 1995 Jun;23(6):1080-9.

PMID:
7774220
5.

In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons.

Mestries JC, Kruithof EK, Gascon MP, Herodin F, Agay D, Ythier A.

Eur Cytokine Netw. 1994 May-Jun;5(3):275-81.

PMID:
7948765
6.

Protective effect of natural TNF-binding protein on human TNF-induced toxicity in mice.

Ythier A, Gascon MP, Juillard P, Vesin C, Wallach D, Grau GE.

Cytokine. 1993 Sep;5(5):459-62.

PMID:
8142601
7.

Urinary TNF-binding protein (TNF soluble receptor) protects mice against the lethal effect of TNF and endotoxic shock.

Bertini R, Delgado R, Faggioni R, Gascon MP, Ythier A, Ghezzi P.

Eur Cytokine Netw. 1993 Jan-Feb;4(1):39-42.

PMID:
8387827
8.

Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons.

Herodin F, Mestries JC, Janodet D, Martin S, Mathieu J, Gascon MP, Pernin MO, Ythier A.

Blood. 1992 Aug 1;80(3):688-95.

PMID:
1638022
9.

Pharmacokinetics and tissue distribution of human urinary tumor necrosis factor binding protein in mice.

Gascon MP, Porchet HC, Le Cotonnec JY, Ythier A, Wallach D, Piguet PF, Grau GE.

Drug Metab Dispos. 1992 Jul-Aug;20(4):592-5.

PMID:
1356740
10.

In vitro forecasting of drugs which may interfere with the biotransformation of midazolam.

Gascon MP, Dayer P.

Eur J Clin Pharmacol. 1991;41(6):573-8.

PMID:
1815969
11.

Impact of environmental and genetic factors on codeine analgesia.

Desmeules J, Gascon MP, Dayer P, Magistris M.

Eur J Clin Pharmacol. 1991;41(1):23-6.

PMID:
1782973
12.

[Drug interactions of midazolam].

Gascon MP, Dayer P, Waldvogel F.

Schweiz Med Wochenschr. 1989 Dec 16;119(50):1834-6. French.

PMID:
2609139
13.

[Evaluation of a caffeine test for determining the phenotype of N-acetyltransferase].

Gascon MP, Leemann T, Dayer P.

Schweiz Med Wochenschr. 1987 Dec 5;117(49):1974-6. French.

PMID:
3423781

Supplemental Content

Loading ...
Support Center